Related Experiment Video
Updated: Mar 20, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Associations of dysnatremias with mortality in chronic kidney disease
Haiquan Huang1,2, Stacey E Jolly3, Medha Airy4
1Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Insights
In patients with chronic kidney disease (CKD), both low (hyponatremia) and high (hypernatremia) serum sodium levels increase mortality risk. Hyponatremia is linked to cardiovascular, malignancy, and other deaths, while hypernatremia is associated with non-cardiovascular/non-malignancy deaths.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Research
Background:
- Hyponatremia and hypernatremia are linked to increased mortality in the general population and patients with chronic kidney disease (CKD).
- Understanding the specific mortality risks associated with dysnatremias in CKD patients is crucial for clinical management.
Purpose of the Study:
- To investigate the associations between hyponatremia and hypernatremia and all-cause mortality in patients with Stage 3 and 4 CKD.
- To examine the relationships between dysnatremias and specific causes of death, including cardiovascular, malignancy-related, and other causes.
Main Methods:
- A large cohort of 45,333 patients with Stage 3 and 4 CKD was analyzed.
- Cox proportional hazards and competing risk models were employed to assess the associations between serum sodium levels (hyponatremia <136 mmol/L, hypernatremia >145 mmol/L) and mortality outcomes.
Main Results:
- Dysnatremias were present in 9.2% of the study cohort.
- Both hyponatremia and hypernatremia were independently associated with all-cause mortality.
- Hyponatremia increased the risk of cardiovascular, malignancy-related, and non-cardiovascular/non-malignancy deaths.
- Hypernatremia was significantly associated with an increased risk of non-cardiovascular/non-malignancy deaths.
Conclusions:
- In CKD patients, hyponatremia is associated with increased all-cause mortality and specific causes of death (cardiovascular, malignancy, other).
- Hypernatremia in CKD patients is linked to increased all-cause and non-cardiovascular/non-malignancy mortality.
- Further research is needed to understand the underlying mechanisms driving these cause-specific mortality differences in dysnatremias among CKD patients.
Background:
Hyponatremia and hypernatremia are associated with death in the general population and those with chronic kidney disease (CKD). We studied the associations between dysnatremias, all-cause mortality and causes of death in a large cohort of Stage 3 and 4 CKD patients.
Methods:
We included 45 333 patients with Stage 3 and 4 CKDs followed in a large healthcare system. Associations between hyponatremia (<136 mmol/L) and hypernatremia (>145), and all-cause mortality and causes of death (cardiovascular, malignancy related and non-cardiovascular/non-malignancy related) were studied using Cox proportional hazards and competing risk models.
Results:
Dysnatremias were found in 9.2% of the study population. In separate multivariable Cox proportional hazards models using baseline serum sodium levels and time-dependent repeated measures, both hyponatremia and hypernatremia were associated with all-cause mortality. In the competing risk analyses, hyponatremia was significantly associated with increased risk for various cause-specific mortality categories [cardiovascular (hazard ratio, HR 1.16, 95% confidence interval, CI: 1.04, 1.30), malignancy related (HR 1.48, 95% CI: 1.33, 1.65) and non-cardiovascular/non-malignancy deaths (HR 1.25, 95% CI: 1.13, 1.39)], while hypernatremia was significantly associated with higher non-cardiovascular/non-malignancy mortality only (HR 1.36, 95% CI: 1.08, 1.72).
Conclusions:
In those with CKD, hyponatremia was associated with all-cause mortality, cardiovascular, malignancy and non-cardiovascular/non-malignancy-related deaths. Hypernatremia was associated with all-cause and non-cardiovascular/non-malignancy-related deaths. Further studies are needed to elucidate the mechanisms of differences in cause-specific death among CKD patients with hyponatremia and hypernatremia.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction

